431 related articles for article (PubMed ID: 17877289)
21. Pharmacogenomics.
Tribut O; Lessard Y; Reymann JM; Allain H; Bentué-Ferrer D
Med Sci Monit; 2002 Jul; 8(7):RA152-63. PubMed ID: 12119546
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenomics in gastrointestinal disorders.
Camilleri M; Saito YA
Methods Mol Biol; 2008; 448():395-412. PubMed ID: 18370239
[TBL] [Abstract][Full Text] [Related]
23. [Pharmacogenetics: towards personalized medicine].
Gurwitz D; Rehavi M
Harefuah; 2005 Oct; 144(10):711-6, 750. PubMed ID: 16281764
[TBL] [Abstract][Full Text] [Related]
24. Genomics and personalized medicine.
Meadows M
FDA Consum; 2005; 39(6):12-7. PubMed ID: 16669113
[No Abstract] [Full Text] [Related]
25. Human genome project: pharmacogenomics and drug development.
Ganguly NK; Bano R; Seth SD
Indian J Exp Biol; 2001 Oct; 39(10):955-61. PubMed ID: 11883519
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenetics of asthma.
Hawkins GA; Peters SP
Methods Mol Biol; 2008; 448():359-78. PubMed ID: 18370237
[TBL] [Abstract][Full Text] [Related]
27. Assessing patient readiness for the clinical adoption of personalized medicine.
Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
[TBL] [Abstract][Full Text] [Related]
28. Role of genomics on the path to personalized medicine.
Tremblay J; Hamet P
Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.
Siest G; Marteau JB; Maumus S; Berrahmoune H; Jeannesson E; Samara A; Batt AM; Visvikis-Siest S
Eur J Pharmacol; 2005 Dec; 527(1-3):1-22. PubMed ID: 16316654
[TBL] [Abstract][Full Text] [Related]
30. Progress in pharmacogenomics and its promise for medicine.
Blake CA; Sobel BE
Exp Biol Med (Maywood); 2008 Dec; 233(12):1482-3. PubMed ID: 18849537
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacogenomics and gene expression analysis. Functional genome research for individual application to patients].
Kassack MU
Med Monatsschr Pharm; 2003 May; 26(5):165-6. PubMed ID: 12784508
[No Abstract] [Full Text] [Related]
32. Applications of microarrays and biochips in pharmacogenomics.
Hardiman G
Methods Mol Biol; 2008; 448():21-30. PubMed ID: 18370228
[TBL] [Abstract][Full Text] [Related]
33. The ethical implications of stratifying by race in pharmacogenomics.
Lee SS
Clin Pharmacol Ther; 2007 Jan; 81(1):122-5. PubMed ID: 17186010
[TBL] [Abstract][Full Text] [Related]
34. SNPs and haplotypes: genetic markers for disease and drug response (review).
Shastry BS
Int J Mol Med; 2003 Mar; 11(3):379-82. PubMed ID: 12579344
[TBL] [Abstract][Full Text] [Related]
35. [Customized drug therapy--how near is the goal?].
Spigset O
Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2390-6. PubMed ID: 16998553
[TBL] [Abstract][Full Text] [Related]
36. G protein-coupled receptor pharmacogenetics.
Thompson MD; Siminovitch KA; Cole DE
Methods Mol Biol; 2008; 448():139-85. PubMed ID: 18370234
[TBL] [Abstract][Full Text] [Related]
37. [Basic problems and tasks of clinical pharmacogenetics].
Skakun NP
Klin Med (Mosk); 1980 Jan; 58(1):11-6. PubMed ID: 6988636
[No Abstract] [Full Text] [Related]
38. Cancer pharmacogenetics.
Marsh S
Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
[TBL] [Abstract][Full Text] [Related]
39. The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
Hodge AE; Altman RB; Klein TE
Clin Pharmacol Ther; 2007 Jan; 81(1):21-4. PubMed ID: 17185992
[TBL] [Abstract][Full Text] [Related]
40. A piece in the puzzle of personalized medicine.
Kroemer HK; Meyer zu Schwabedissen HE
Clin Pharmacol Ther; 2010 Jan; 87(1):19-20. PubMed ID: 20019696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]